Navigation Links
New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
Date:9/12/2007

d Staphylococcus aureus bacteraemia (SAB) when associated with RIE or with cSSTI.

Daptomycin is an antibiotic with a distinct mode of action which has several notable features, including once-daily dosing and no requirement for serum drug monitoring, which may reduce the burden on healthcare professionals and hospitalisation costs.

About Novartis

Novartis AG (NYSE: NVS) is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 100,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

References

(1). Cubicin SPC, September 2007

(2). Fowler VG, Jr. et al. New Eng Jour med 2006;355(7):653-65

(3). Department of Health. MRSA surveillance system: Results. Accessed on 18 July 2007. Available at: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/Publica
'/>"/>

SOURCE Novartis Pharmaceuticals UK Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. The Genesis of Gendicine: The Story Behind the First Gene Therapy
2. Midwest life science stocks sizzle in a tepid first quarter
3. Morgridge Institute for Research seeks first CEO
4. Sonic Foundry reports first cash-positive quarter
5. Angel investors commit $12.7B in first half of `06
6. Aurora team implants Wisconsins first total artificial heart
7. First half of 2006 roundup: Big Pharma trumps biotech
8. GE announces first installation of Discovery VCT
9. GE Healthcare enjoys robust growth in first quarter
10. Madison asks for wireless bids; airport, downtown would be first
11. Tech Digest: Inacom, PKWare at Infosecurity, Firstlogic, Teklynx
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 Freeslate, ... solutions, today announced that Lupin Limited, one of India’s ... CM Protégé PharmD System for high throughput ... India, is focused on a wide range of quality, ...
(Date:1/14/2014)... Carahsoft and CDS Federal Services have scheduled ... 2pm EST (11am PST), “Natural Language Processing: Converting Raw ... technology can turn raw, heterogeneous data into actionable knowledge ... online webinar will last approximately one hour. , Synopsis: ...
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an ... products to serve the wound care market. , Free ... Alliqua was restructured with a seasoned management team and ...
(Date:1/14/2014)... In recent years, growing suspicion about ... product development and promotion has led to unprecedented levels ... by concerns about the insidious impact of commercialization of ... fines to the world’s biggest pharmas for illegal marketing ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... ITMN ) today announced that Dan Welch, President ... Bank of America 2008,Health Care Conference in Las Vegas ... EDT)., To access a live audio webcast of ... to the investor relations page of InterMune,s,corporate website at ...
... Mass., May 9 Inverness Medical,Innovations (Amex: ... previously announced,acquisition of Matria Healthcare, Inc. was ... of business today, May 9, 2008. Matria,headquartered ... services particularly in the areas of women,s ...
... ... earnings growth., ST. DAVID,S, Bermuda, May 9 ... quarter ended,March 31, 2008. Revenue in the quarter ended March 31, 2008 ... primary,drivers of the increase in revenue were the net sales of our ...
Cached Biology Technology:Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc. 2Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 2Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 3Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 4Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 5Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 6Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 7Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 8Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 9Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 10Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 11Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 12Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 13Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 14Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 15Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 16Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 17
(Date:4/20/2014)... pancreatic cancers also promote drug-resistance and ultimately spur tumor ... School of Medicine have discovered a molecule, or biomarker, ... appears responsible for inducing tumor metastasis by enhancing the ... findings, published in the April 20, 2014 online issue ... new therapeutic opportunities for reversing drug resistance in a ...
(Date:4/18/2014)... of emergency contraceptive pills in Peru found that ... of substandard quality or falsified. Many pills released ... wrong active ingredient. One batch had no active ... fake drugs, researchers at the Georgia Institute of ... to quickly assess suspected counterfeit drugs and then ...
(Date:4/18/2014)... DNA adds a twist to the story of how barnyard ... April 21 in the journal Proceedings of the National ... of chickens that lived 200-2300 years ago in Europe, researchers ... may have looked far different from the chickens we know ... we associate with modern domestic chickens -- such as their ...
Breaking Biology News(10 mins):Cancer stem cells linked to drug resistance 2Counterfeit contraceptives found in South America 2Counterfeit contraceptives found in South America 3Ancient DNA offers clues to how barnyard chickens came to be 2
... funded by the Government of Canada, today announced $100,000 ... income countries worldwide to pursue bold, creative ideas to ... also announced for 17 Canadian-based projects to be implemented ... will mimic rocket technology to propel coagulant nanoparticles into ...
... is living in your gut, and what they,re doing? The ... our own cells by as many as 10 to 1 ... the food we eat this Thanksgiving to building up our ... researchers at the University of Colorado Boulder along with researchers ...
... The days of researching cell behavior by using the ... fluorescence microscopes have gone. Microscopy has now reached the ... mathematics, and a new field is emerging at the ... how scientists study fundamental questions of cell behavior. ...
Cached Biology News:Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 2Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 3Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 4Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 5Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 6Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 7Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 8Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 9Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 10Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 11Inspired: Canada funds 68 bold, inventive ways to improve health, save lives in developing countries 12New public gut bacteria study expected to reach around world 2New public gut bacteria study expected to reach around world 3New public gut bacteria study expected to reach around world 4A multidisciplinary approach and a new field help to understand cell behavior 2
Goat polyclonal to Dysadherin ( Abpromise for all tested applications). entrezGeneID: 53827...
This antibody detects an ~25 kDa band, corresponding to the expected molecular mass of Rab3A, on immunoblots. The antibody specificity is confirmed in peptide inhibition immunoblotting studies....
... 100 g of monoclonal antibody reactive against ... of SURF1 are highest in growing cultured cells. ... c oxidase which is thought to participate in ... insertion into this subunit. Mutations of SURF1, particularly ...
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Biology Products: